AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

(MedPage Today) -- Investigational drug ularitide had no effect on mortality or clinical outcomes
via AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator
by